Works matching IS 10837159 AND DT 2021 AND VI 26 AND IP 9
Results: 33
The Occasional Reader.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. e1484, doi. 10.1002/onco.13929
- Publication type:
- Article
Study to Compare Capsule and Liquid Formulations of Enzalutamide After Single‐Dose Administration Under Fasting Conditions in Prostate Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. 729, doi. 10.1002/onco.13919
- By:
- Publication type:
- Article
Characterization and Management of Adverse Reactions in Patients with Advanced Endometrial Carcinoma Treated with Lenvatinib Plus Pembrolizumab.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. e1599, doi. 10.1002/onco.13883
- By:
- Publication type:
- Article
Regarding HER2‐Amplified Biliary Tract Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. e1664, doi. 10.1002/onco.13872
- Publication type:
- Article
The Matilda Effect: Underrecognition of Women in Hematology and Oncology Awards.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. 779, doi. 10.1002/onco.13871
- By:
- Publication type:
- Article
Identification of Somatic Gene Signatures in Circulating Cell‐Free DNA Associated with Disease Progression in Metastatic Prostate Cancer by a Novel Machine Learning Platform.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. 751, doi. 10.1002/onco.13869
- By:
- Publication type:
- Article
It Takes Two to Tango: Patients' and Providers' Perspectives in Tobacco Cessation and Head/Neck Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. 761, doi. 10.1002/onco.13856
- By:
- Publication type:
- Article
Causes of Death Following Nonmetastatic Colorectal Cancer Diagnosis in the U.S.: A Population‐Based Analysis.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. 733, doi. 10.1002/onco.13854
- By:
- Publication type:
- Article
Multidisciplinary Care of BRAF‐Mutant Stage III Melanoma: A Physicians Perspective Review.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. e1644, doi. 10.1002/onco.13852
- By:
- Publication type:
- Article
Single‐Center Analysis of Characteristics and Outcomes of De Novo, Concurrent, and Transformed Diffuse Large B‐Cell Lymphoma.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. e1660, doi. 10.1002/onco.13846
- By:
- Publication type:
- Article
Real‐World Clinical Outcomes in Patients with Locally Advanced or Metastatic Merkel Cell Carcinoma Treated in U.S. Oncology Clinical Practices: Results from SPEAR‐Merkel.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. e1633, doi. 10.1002/onco.13845
- By:
- Publication type:
- Article
Comparative Genomic Analysis of Intrahepatic Cholangiocarcinoma: Biopsy Type, Ancestry, and Testing Patterns.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. 787, doi. 10.1002/onco.13844
- By:
- Publication type:
- Article
Prognostic Role of Circulating Tumor Cells in Metastatic Renal Cell Carcinoma: A Large, Multicenter, Prospective Trial.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. 740, doi. 10.1002/onco.13842
- By:
- Publication type:
- Article
Early Weight Loss as a Prognostic Factor in Patients with Advanced Gastric Cancer: Analyses from REGARD, RAINBOW, and RAINFALL Phase III Studies.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. e1538, doi. 10.1002/onco.13836
- By:
- Publication type:
- Article
COVID‐19 in Patients with Cancer: A Retrospective Study of 212 Cases from a French SARS‐CoV‐2 Cluster During the First Wave of the COVID‐19 Pandemic.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. e1656, doi. 10.1002/onco.13831
- By:
- Publication type:
- Article
Homologous Recombination Deficiency: Cancer Predispositions and Treatment Implications.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. e1526, doi. 10.1002/onco.13829
- By:
- Publication type:
- Article
Humoral Immune Response of SARS‐CoV‐2–Infected Patients with Cancer: Influencing Factors and Mechanisms.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. e1619, doi. 10.1002/onco.13828
- By:
- Publication type:
- Article
Treatment Patterns and Outcomes in Chinese Patients with Gastric Cancer by HER2 Status: A Noninterventional Registry Study (EVIDENCE).
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. e1567, doi. 10.1002/onco.13826
- By:
- Publication type:
- Article
FDA Approval Summary: Nivolumab Plus Ipilimumab for the Treatment of Patients with Hepatocellular Carcinoma Previously Treated with Sorafenib.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. 797, doi. 10.1002/onco.13819
- By:
- Publication type:
- Article
Total Neoadjuvant Therapy (TNT) versus Standard Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: A Systematic Review and Meta‐Analysis.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. e1555, doi. 10.1002/onco.13824
- By:
- Publication type:
- Article
Personal Payments from Pharmaceutical Companies to Authors of Oncology Clinical Practice Guidelines.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. 771, doi. 10.1002/onco.13823
- By:
- Publication type:
- Article
Relative Dose Intensity of Chemotherapy and Survival in Patients with Advanced Stage Solid Tumor Cancer: A Systematic Review and Meta‐Analysis.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. e1609, doi. 10.1002/onco.13822
- By:
- Publication type:
- Article
A Case of a Pathological Complete Response to Neoadjuvant Nivolumab plus Ipilimumab in Periampullary Adenocarcinoma.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. 722, doi. 10.1002/onco.13821
- By:
- Publication type:
- Article
Succinate Dehydrogenase‐Deficient Renal Cancer Featuring Fructose‐1,6‐Biphosphatase Loss, Pyruvate Kinase M2 Overexpression, and SWI/SNF Chromatin Remodeling Complex Aberrations: A Rare Case Report.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. e1652, doi. 10.1002/onco.13825
- By:
- Publication type:
- Article
First‐in‐Human Phase I Study of Envafolimab, a Novel Subcutaneous Single‐Domain Anti‐PD‐L1 Antibody, in Patients with Advanced Solid Tumors.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. e1514, doi. 10.1002/onco.13817
- By:
- Publication type:
- Article
Recurrence Outcomes Less Favorable in T1 Rectal Cancer than in T1 Colon Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. e1548, doi. 10.1002/onco.13815
- By:
- Publication type:
- Article
Opportunities for Improvement in the Administration of Neoadjuvant Chemotherapy for T4 Breast Cancer: A Comparison of the U.S. and Nigeria.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. e1589, doi. 10.1002/onco.13814
- By:
- Publication type:
- Article
Phase I Trial of Cemiplimab, Radiotherapy, Cyclophosphamide, and Granulocyte Macrophage Colony‐Stimulating Factor in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. e1508, doi. 10.1002/onco.13810
- By:
- Publication type:
- Article
Outcomes and Prognostic Factors of Patients with Metastatic Colorectal Cancer Who Underwent Pulmonary Metastasectomy with Curative Intent: A Brazilian Experience.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. e1581, doi. 10.1002/onco.13802
- By:
- Publication type:
- Article
HER2 Splice Site Mutation c.1899‐1G>A as the Potential Acquired Resistance to Trastuzumab in a Patient with HER2‐Positive Gastric Adenocarcinoma.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. 717, doi. 10.1002/onco.13799
- By:
- Publication type:
- Article
A Phase II Study of Durvalumab in Combination with Tremelimumab in Patients with Rare Cancers.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. e1499, doi. 10.1002/onco.13798
- By:
- Publication type:
- Article
Efficacy and Safety of Trametinib in Non‐V600 BRAF Mutant Melanoma: A Phase II Study.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. 731, doi. 10.1002/onco.13795
- By:
- Publication type:
- Article
Antibiotics and Imiquimod for Cutaneous T‐Cell Lymphoma in Veterans: A Patient Population with Agent Orange Exposure.
- Published in:
- Oncologist, 2021, v. 26, n. 9, p. 727, doi. 10.1002/onco.13785
- By:
- Publication type:
- Article